CurrentRheuma
Get Weekly

Topic · page 4 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 121–160 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

  1. Lupus Sci Med

    Occurrence of venous thromboembolism in SLE: findings from a nationwide cohort and a clinical cohort in Sweden

    Cohort study

  2. Lupus Sci Med

    Diagnostic value of cerebrospinal fluid antisuprabasin antibody in neuropsychiatric systemic lupus erythematosus

    Diagnostic or prognostic study

  3. Lupus Sci Med

    High disease activity persists in adults with childhood-onset lupus

    Cohort study

  4. Lupus

    Network meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis

    Meta-analysis

  5. Lupus

    Validation and prognostic utility of SLERPI in a single-centre retrospective Central European cohort

    Diagnostic or prognostic study

  6. Lupus Sci Med

    Peripheral blood CD19+B cell proportion at baseline predicts early complete response to belimumab treatment in patients with refractory lupus nephritis

    Cohort study

  7. Arthritis Care Res (Hoboken)

    Optimizing Hydroxychloroquine Blood Levels and Long‐Term Hydroxychloroquine Intake Could Lower Atherosclerotic Cardiovascular Disease Risk and Prevent Polypharmacy in Systemic Lupus Erythematosus

    Cohort study

  8. J Rheumatol

    Comparative Performance of SLECRISK and PREVENT for Cardiovascular Risk Prediction in Systemic Lupus Erythematosus

    Diagnostic or prognostic study

  9. Lupus Sci Med

    Role of repeat kidney biopsy after 6 months of treatment in proliferative lupus nephritis

    Cohort study

  10. Arthritis Res Ther

    Patterns of the gut microbiota and metabolome as potential biomarkers associated with influenza vaccine immunogenicity in systemic lupus erythematosus: a cross-sectional observational pilot study

    Cross-sectional study

  11. Arthritis Res Ther

    Early risk stratification in lupus nephritis based on established prognostic factors: association with outcomes under triple therapy

    Cohort study

  12. Lupus

    Clinical phenotypes and disease outcomes of patients with systemic lupus erythematosus meeting indication for primary aldosteronism testing

    Cohort study

  13. Lupus

    Impact of parenting on patient-reported outcomes in female patients with systemic lupus erythematosus: A cross-sectional study of the LUNA registry

    Cross-sectional study

  14. RMD Open

    Prognostic value of antiphospholipid antibodies in pregnancy outcomes in systemic lupus erythematosus

    Cohort study

  15. Rheumatology (Oxford)

    Genome-wide methylation profiling identifies signatures of pain, fatigue and health scores in women with systemic lupus erythematosus

    Cohort study

  16. Lupus

    Persistence of antimalarial therapy and its effect on mortality in systemic lupus erythematosus: A population-based longitudinal multistate study

    Cohort study

  17. Rheumatology (Oxford)

    Prolonged serologically active clinically quiescent systemic lupus erythematosus: a longitudinal study on the role of IgG anti-dsDNA and C3

    Cohort study

  18. Lupus Sci Med

    Lupus Nexus: developing a prospective registry, biorepository and data exchange platform to foster global collaborations, accelerate research innovation and advance precision medicine in lupus

    Cohort study

  19. Lupus

    Serum C-reactive protein levels can predict organ damage in patients with SLE with the lupus low disease activity state

    Cohort study

  20. Lupus Sci Med

    Targeting type I interferon in lupus autoimmune haemolytic anaemia: first report with anifrolumab

    Cohort study

  21. Lupus Sci Med

    Risk of falls, recurrent falls and osteoporotic fractures in SLE patients with comorbid fibromyalgia: a propensity score-matched cohort study using the TriNetX Network

    Cohort study

  22. Arthritis Care Res (Hoboken)

    Employment Trajectories of Patients With Systemic Lupus Erythematosus and Factors Driving Transitions Between States

    Cohort study

  23. Rheumatology (Oxford)

    One-carbon metabolism upregulated in lupus promotes the differentiation and effector functions of human B and T cells

    Mechanistic study

  24. Lupus Sci Med

    Circulating kidney injury molecule-1 as a prognostic biomarker for long-term renal outcomes in lupus nephritis: a retrospective cohort study

    Cohort study

  25. Ann Rheum Dis

    CNS immune remodelling in SLE associated with anti-CD19 CAR-T therapy

    Mechanistic study

  26. Lupus Sci Med

    Glucocorticoid exposure and social support deficits as longitudinal predictors of long-term neuropsychiatric damage in SLE: insights from the LUMINA cohort (LXXXIII)

    Cohort study

  27. Rheumatology (Oxford)

    Characterizing arthritis subtypes in lupus: prevalence, clinical features and role of type I interferon signatures

    Cohort study

  28. Lupus Sci Med

    Harnessing AI and social media to understand real-world patient experiences in SLE

    Cross-sectional study

  29. Lupus Sci Med

    Prevalence and clinical associations of cerebral atrophy in systemic lupus erythematosus

    Cross-sectional study

  30. Lupus Sci Med

    Impact of belimumab on the utility of serological markers for assessing systemic lupus erythematosus activity

    Cohort study

  31. Rheumatology (Oxford)

    Kidney-infiltrating proteinase 3-positive granulocytes are abundant in lupus nephritis

    Mechanistic study

  32. RMD Open

    GLP-1 receptor agonists in systemic lupus erythematosus: a scoping review

    Research article

  33. Lupus Sci Med

    Real-world treatment patterns and outcomes in moderate-to-severe SLE: findings from the Spanish SPOCS cohort

    Cohort study

  34. RMD Open

    Serum IgA autoantibody profiling in systemic lupus erythematosus reveals associations with disease phenotypes

    Cross-sectional study

  35. Lupus Sci Med

    Integrated immune profiling identifies a coordinated T-cell activation and inflammatory signature in SLE

    Mechanistic study

  36. Arthritis Rheumatol

    The Role of Anti‐Phosphatidylserine/Prothrombin Antibodies and the Lectin Complement Pathway in Anti‐Phospholipid Antibody‐Associated Preterm Delivery

    Cohort study

  37. Lupus Sci Med

    International development of a lupus-specific instrument to assess cognitive symptoms in patients with SLE: Lupus Brain Fog Severity Scale (LBFSS) study

    Diagnostic or prognostic study

  38. Rheumatology (Oxford)

    Assessing the mortality burden after acute myocardial infarction in SLE: insights from the MINAP Registry

    Cohort study

  39. Rheumatology (Oxford)

    Disparities in severe infection risk associated with SLE: evidence from a causal forest analysis

    Cohort study

  40. Ann Rheum Dis

    Development and validation of quality indicators for lupus nephritis, based on the 2025 EULAR recommendations: adherence trends and impact on clinical outcomes

    Diagnostic or prognostic study

All 1,848 Briefs in ExploreShowing Briefs 121–160 of 1,848, newest first